NAOV

NanoVibronix, Inc. (NASDAQ:NAOV) is a medical device company founded in 2003 and headquartered in Elmsford, New York. The company specializes in developing and manufacturing noninvasive ultrasound-based therapeutic devices that target biofilm prevention, wound healing, and pain management. Through its Israeli subsidiary NanoVibronix Ltd., the company has developed a portfolio of ultrasound patch technologies that leverage low-frequency surface acoustic waves to provide therapeutic benefits. Since going public in 2015, NanoVibronix has focused on commercializing its proprietary ultrasound platform across multiple medical applications, selling products both directly to patients and through distributor networks in the United States, Israel, Europe, India, and other international markets.